Details of the Drug Reposition

General Information of This Drug (ID: DM8DT7U)

Drug Name
ABT-089   DM8DT7U
Synonyms
Pozanicline; A 94224; ABT 089; Pozanicline (USAN); (R)-2-Methyl-3-(2-pyrrolidinylmethoxy)pyridine; 2-Methyl-3-(2-pyrrolidinylmethoxy)pyridine; 2-Methyl-3-(2S-pyrrolidinylmethoxy)pyridine; 2-methyl-3-[[(2R)-pyrrolidin-2-yl]methoxy]pyridine; 2-methyl-3-[[(2S)-pyrrolidin-2-yl]methoxy]pyridine
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
4 Discontinued in Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Attention deficit hyperactivity disorder DISL8MX9 6A05.Z Discontinued in Phase 2 [1]
Schizophrenia DISSRV2N 6A20 Discontinued in Phase 2 [1]
Anxiety disorder DISBI2BT 6B00-6B0Z Discontinued in Phase 2 [1]
Dementia DISXL1WY 6D80-6D86 Discontinued in Phase 2 [1]
------------------------------------------------------------------------------------

References

1 Emerging drugs for attention-deficit/hyperactivity disorder. Expert Opin Emerg Drugs. 2007 Sep;12(3):423-34.